New Pharmacological Perspectives and Therapeutic Potential of PPAR-&ggr; Agonists

By  

Current Pharmaceutical Design, Vol. 10, Iss. 28, 2004-11 ,pp. : 3505-3524

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of γ-Secretase as a Therapeutic Intervention for Alzheimer's Disease: Prospects, Limitations and Strategies

By Evin Geneviève   Marijke Fleur Sernee   Masters Colin L.  

CNS Drugs, Vol. 20, Iss. 5, 2006-01 ,pp. : 351-372

Adis International

Access to resources Recommend Favorite

The Role of Peroxisome Proliferator-Activated Receptor-γ (PPARγ) in Alzheimer's Disease: Therapeutic Implications

By Jiang Qingguang  

CNS Drugs, Vol. 22, Iss. 1, 2008-01 ,pp. : 1-14

Adis International

Access to resources Recommend Favorite

Therapeutic Potential of Aleglitazar, a New Dual PPAR-α/γ Agonist: Implications for Cardiovascular Disease in Patients with Diabetes Mellitus

By Cavender Matthew A.   Lincoff A. Michael  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 4, 2010-08 ,pp. : 209-216

Adis International

Access to resources Recommend Favorite

PPAR-γ signaling pathway in placental development and function: A potential therapeutic target in the treatment of gestational diseases

By Giaginis Costas   Spanopoulou Evangelia   Theocharis Stamatios  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 8, 2008-08 ,pp. : 1049-1063

Informa Healthcare

Access to resources Recommend Favorite